UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Cary Street Partners Asset Management LLC

Cary Street Partners Asset Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 4.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 803 shares of the healthcare conglomerate’s stock after purchasing an additional 36 shares during the period. Cary Street Partners Asset Management LLC’s holdings in UnitedHealth Group were worth $470,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. China Universal Asset Management Co. Ltd. boosted its holdings in UnitedHealth Group by 20.6% in the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after purchasing an additional 1,857 shares during the period. Quent Capital LLC raised its stake in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after acquiring an additional 217 shares during the period. Embree Financial Group grew its holdings in shares of UnitedHealth Group by 12.1% during the first quarter. Embree Financial Group now owns 613 shares of the healthcare conglomerate’s stock valued at $303,000 after purchasing an additional 66 shares during the last quarter. Valley Wealth Managers Inc. boosted its position in UnitedHealth Group by 8.7% during the 1st quarter. Valley Wealth Managers Inc. now owns 1,149 shares of the healthcare conglomerate’s stock valued at $568,000 after purchasing an additional 92 shares during the period. Finally, SPC Financial Inc. increased its position in UnitedHealth Group by 3.6% in the first quarter. SPC Financial Inc. now owns 5,185 shares of the healthcare conglomerate’s stock worth $2,565,000 after buying an additional 179 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.6 %

Shares of UNH opened at $566.96 on Wednesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The business’s 50-day moving average price is $580.96 and its 200 day moving average price is $543.36. The stock has a market capitalization of $523.54 billion, a P/E ratio of 36.94, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the business posted $6.56 EPS. Analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Robert W. Baird increased their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Stephens cut their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 24th. UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Finally, Argus increased their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

Check Out Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.